Antioral cancer effects of ginger derivative 3-HDM exert oxidative stress-associated apoptosis and DNA damage
Molecular Biology Reports · 2025
DOI: 10.1007/s11033-025-10514-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Biology Reports, 2025. Verfasst von Kuan-Liang Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, Chi-Mei Medical Center, Tainan, 71004, Taiwan. Hauptthemen laut MEDLINE: Oxidative Stress, Apoptosis, Zingiber officinale, DNA Damage. Die Arbeit nennt 58 Literaturangaben. Gefördert von: Chimei-KMU jointed project, Ministry of Science and Technology, Taiwan, Kaohsiung Medical University Research Center.
Abstract (Originalsprache)
BACKGROUND: 3-Hydroxy-1-(3',5'-dimethoxy-4'-hydroxy-phenyl)-hexan-5-one (3-HDM), a novel ginger Zingiber officinale-derived compound, lacks anti-cancer investigation, especially for oral cancer. This study addresses the antioral function and mechanism of 3-HDM against oral cancer cells (Ca9-22 and CAL 27). METHOD: MTS, flow cytometry, and western blotting were used to determine cell viability and antioral function and mechanism. RESULTS: 3-HDM inhibits oral cancer cell viability without normal cell (S-G) toxicity. This selective antiproliferation relies on oxidative stress validated by N-acetylcysteine (NAC), a reactive oxygen species (ROS) remover. 3-HDM upregulates subG1 and annexin V proportions, enhances caspases 3 and 8 activation to a greater extent in oral cancer than in normal cells, reverted by NAC. This process demonstrates the ROS-dependent selective apoptotic character of 3-HDM. 3-HDM also upregulates more ROS and mitochondrial superoxide and downregulates the mitochondrial membrane potential and glutathione in oral cancer than in normal cells in a ROS-dependent manner. Moreover, 3-HDM suppresses antioxidant signaling mRNA expressions such as NFE2L2, NQO1, and TXN and inhibits NFE2L2 phosphorylation in oral cancer cells compared to normal cells. NAC also downregulates the 3-HDM-induced γH2AX and 8-hydroxy-2-deoxyguanosine DNA damage markers. CONCLUSION: 3-HDM shows selective antioral cancer effects and mechanisms without toxicity to normal cells via oxidative stress regulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral and Maxillofacial Surgery, Chi-Mei Medical Center, Tainan, 71004, Taiwan.
- Department of Biomedical Science and Environmental Biology, PhD Program in Life Sciences, College of Life Science, Kaohsiung Medical University, Kaohsiung, 80708, Taiwan.
- School of Dentistry, Taipei Medical University, Taipei, 11031, Taiwan.
- School of Medical and Health Sciences, Fooyin University, Kaohsiung, 83102, Taiwan.
- School of Post-Baccalaureate Medicine, Kaohsiung Medical University, Kaohsiung, 80708, Taiwan.
- Department of Urology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, 80708, Taiwan.
Förderung
- Chimei-KMU jointed project
- Ministry of Science and Technology, Taiwan
- Kaohsiung Medical University Research Center
- Kaohsiung Medical University
Zitieren
APA
Chen, K. L., Lu, H. I., Yen, C. Y., Chen, C. Y., Chien, T. M., Jeng, J. H., Chen, B. H., & Chang, H. W. (2025). Antioral cancer effects of ginger derivative 3-HDM exert oxidative stress-associated apoptosis and DNA damage. Molecular Biology Reports. https://doi.org/10.1007/s11033-025-10514-2
Vancouver
Chen KL, Lu HI, Yen CY, Chen CY, Chien TM, Jeng JH, et al. Antioral cancer effects of ginger derivative 3-HDM exert oxidative stress-associated apoptosis and DNA damage. Molecular Biology Reports. 2025. doi:10.1007/s11033-025-10514-2
BibTeX
@article{Chen2025,
author = {Chen, Kuan-Liang and Lu, Hsin-I and Yen, Ching-Yu and Chen, Chung-Yi and Chien, Tsu-Ming and Jeng, Jiiang-Huei and Chen, Bing-Hung and Chang, Hsueh-Wei},
title = {Antioral cancer effects of ginger derivative 3-HDM exert oxidative stress-associated apoptosis and DNA damage},
journal = {Molecular Biology Reports},
year = {2025},
doi = {10.1007/s11033-025-10514-2}
}
EUVIMED